Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin

Applied and Environmental Microbiology

Volumn 78, Issue 14, 2012, Pages 4967-4975

  Wang, Rongzhi ^a   Fang, Sui ^a   Wu, Dinglong ^a   Lian, Junwei ^a   Fan, Jue ^a   Zhang, Yanfeng ^b   Wang, Shihua ^a   Lin, Wenxiong ^a  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL HEALTH; CELL TOXICITY; FOOD BORNE DISEASE; HALOPHILIC BACTERIA; PATHOGENIC FACTORS; PHAGE DISPLAY SCREENING; V. PARAHAEMOLYTICUS; VIBRIO PARAHAEMOLYTICUS;

BACTERIA; BLOOD; CYTOTOXICITY; DIAGNOSIS; GENES; VETERINARY MEDICINE; WATER RESOURCES;

ANTIBODIES;

BACTERIAL PROTEIN; HEMOLYSIN; HEMOLYSIN, VIBRIO; NEUTRALIZING ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTECHNOLOGY; FOOD POISONING; GENE EXPRESSION; NEUTRALIZATION; PATHOGEN; PUBLIC HEALTH; TOXICITY; TOXICITY TEST; WATER RESOURCE;

ANIMAL; ANTIBODY AFFINITY; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CELL SURFACE DISPLAY; GENETICS; HELA CELL; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; VIBRIO PARAHAEMOLYTICUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY AFFINITY; BACTERIAL PROTEINS; CELL LINE; CELL SURFACE DISPLAY TECHNIQUES; HELA CELLS; HEMOLYSIN PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; SINGLE-CHAIN ANTIBODIES; VIBRIO PARAHAEMOLYTICUS;

ANIMALIA; BACTERIA (MICROORGANISMS); VIBRIO PARAHAEMOLYTICUS;

EID: 84863771608     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00435-12     Document Type: Article

References (44)

1. Asano R, et al. 2011. Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv). J. Biol. Chem. 286:1812-1818.
2. Barderas R, et al. 2006. A fast mutagenesis procedure to recover soluble and functional scFvs containing amber stop codons from synthetic and semisynthetic antibody libraries. J. Microbiol. Methods 312:182-189.
3. Bej AK, et al. 1999. Detection of total and hemolysin-producing Vibrio parahaemolyticus in shellfish using multiplex PCR amplification of tl, tdh and trh. J. Microbiol. Methods 36:215-225.
4. Boder ET, Midelfort KS, Wittrup KD. 2000. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. U. S. A. 97:10701-10705.
5. Bresee JS, Widdowson MA, Monroe SS, Glass RI. 2002. Foodborne viral gastroenteritis: challenges and opportunities. Clin. Infect. Dis. 35:748-753.
6. Broberg CA, Calder TJ, Orth K. 2011. Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect. 13:992-1001.
7. Burdette DL, Yarbrough ML, Orvedahl A, Gilpin CJ, Orth K. 2008. Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis. Proc. Natl. Acad. Sci. U. S. A. 105:12497-12502.
8. Cattepoel S, Hanenberg M, Kulic L, Nitsch RM. 2011. Chronic intranasal treatment with an anti-Aβ30-42 scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 6:e18296. doi:10.1371/journal.pone.0018296.
9. Cesaro-Tadic S, et al. 2003. Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library. Nat. Biotechnol. 21:679-685.
10. Coia G, Hudson PJ, Irving RA. 2001. Protein affinity maturation in vivo using E. coli mutator cells. J. Immunol. Methods 251:187-193.
11. Dai H, et al. 2003. Construction and characterization of a novel recombinant single-chain variable fragment antibody against white spot syndrome virus from shrimp. J. Immunol. Methods 279:267-275.
12. Doppalapudi VR, et al. 2010. Chemical generation of bispecific antibodies. Proc. Natl. Acad. Sci. U. S. A. 107:22611-22616.
13. Eisenhardt SU, et al. 2007. Generation of activation-specific human antialpha M beta 2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109:3521-3528.
14. Ellison RK, Malnati E, DePaola A, Bowers Rodrick GE. 2001. Popula-tions of Vibrio parahaemolyticus in retail oysters from Florida using two methods. J. Food Prot. 174:682-686.
15. Engelthaler D, et al. 2005. Vibrio illnesses after Hurricane Katrina- multiple states, August-September 2005. MMWR Morb. Mortal. Wkly. Rep. 54:928-931.
16. Fischer R, Emans N. 2000. Molecular farming of pharmaceutical proteins. Transgenic Res. 9:279-299.
17. Hmila I, et al. 2008. VHH, bivalent domains and chimeric heavy chainonly antibodies with high neutralizing efficacy for scorpion toxin AahI. Mol. Immunol. 45:3847-3856.
18. Hoogenboom HR. 2005. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23:1105-1116.
19. Kabat EA, Wu T, Gottesman KS, Foeller C. 1991. Sequences of proteins of immunological interest. Diane Publishing Co., 5th ed. US Department of Health and Human Services, Washington, DC.
20. Kanter G, et al. 2007. Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines. Blood 109:3393-3399.
21. Kawatsu K, Ishibashi M, Tsukamoto T. 2006. Development and evaluation of a rapid, simple, and sensitive immunochromatographic assay to detect thermostable direct hemolysin produced by Vibrio parahaemolyticus in enrichment cultures of stool specimens. J. Clin. Microbiol. 44:1821-1827.
22. Krag DN, et al. 2006. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 66:7724-7733.
23. Liverman ADB, et al. 2007. Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc. Natl. Acad. Sci. U. S. A. 104:17117-17122.
24. Lynch T, et al. 2005. Vibrio parahaemolyticus disruption of epithelial cell tight junctions occurs independently of toxin production. Infect. Immun. 73:1275-1283.
25. Matsuda S, et al. 2010. Association of Vibrio parahaemolyticus thermostable direct hemolysin with lipid rafts is essential for cytotoxicity but not hemolytic activity. Infect. Immun. 78:603-610.
26. Myers ML, Panicker G, Bej AK. 2003. PCR detection of a newly emerged pandemic Vibrio parahaemolyticus O3:K6 pathogen in pure cultures and seeded waters from the Gulf of Mexico. Appl. Environ. Microbiol. 69: 2194-2200.
27. Rinderknecht M, Villa A, Ballmer-Hofer K, Neri D, Detmar M. 2010. Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3. PLoS One 5:e11941. doi:10.1371/journal.pone.0011941.
28. Rothe A, et al. 2007. Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display. J. Biotechnol. 130:448-454.
29. Sakai K, et al. 2010. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments. J. Biochem. 147:809-817.
30. Sakata J, et al. 2012. Production and characterization of a monoclonal antibody against recombinant thermolabile hemolysin and its application to screen for Vibrio parahaemolyticus contamination in raw seafood. Food Control 23:171-176.
31. Shinoda S, et al. 1991. Purification and characterization of a lecithindependent haemolysin from Escherichia coli transformed by a Vibrio parahaemolyticus gene. J. Gen. Microbiol. 137:2705-2708.
32. Singh PK, et al. 2010. Construction of a single-chain variable-fragment antibody against the superantigen staphylococcal enterotoxin B. Appl. Environ. Microbiol. 76:8184-8191.
33. Sommaruga S, et al. 2011. Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells. Appl. Microbiol. Biotechnol. 91:613-621. doi:10.1007/s00253-011-3306-3.
34. Su YC, Liu C. 2007. Vibrio parahaemolyticus: a concern of seafood safety. Food Microbiol. 24:549-558.
35. Taniguchi H, et al. 1990. Cloning and characterization of a gene encoding a new thermostable hemolysin from Vibrio parahaemolyticus. FEMS Microbiol. Lett. 67:339-345.
36. Vora GJ, et al. 2005. Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic Vibrio spp. Proc. Natl. Acad. Sci. U. S. A. 102:19109-19114.
37. Wang RZ, et al. 2011. Detection and identification of Vibrio parahaemolyticus by multiplex PCR and DNA-DNA hybridization on a microarray. J. Genet. Genomics 38:129-135.
38. Wang SH, et al. 2007. Detection of deoxynivalenol based on a single chain fragment variable (scFv) of the antideoxynivalenol antibody. FEMS Microbiol. Lett. 272:214-219.
39. Wang SH, Du XY, Lin L, Huang YM, Wang ZH. 2008. Zearalenone (ZEN) detection by a single chain fragment variable (scFv) antibody. World J. Microbiol. Biotechnol. 24:1681-1685.
40. Wang SH, et al. 2006. Construction of single chain variable fragment (ScFv) and BiscFv-alkaline phosphatase fusion protein for detection of Bacillus anthracis. Anal. Chem. 78:997-1004.
41. Wong ASL, et al. 2011. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease. Nat. Cell Biol. 13:568-591.
42. Wu Z, Nybom P, Magnusson KE. 2000. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2:11-17.
43. Zhang G, Liu Y, Hu H. 2010. Preparation and cytotoxicity effect of anti-hepatocellular carcinoma scFv immunoliposome on hepatocarcinoma cell in vitro. Eur. J. Inflamm. 8:75-82.
44. Zhao YG, Tang XQ, Zhan WB. 2011. Cloning, expression, and hemolysis of tdh, trh and tlh genes of Vibrio parahaemolyticus. J. Ocean. Univ. China 10:275-279.